Cathepsin B-Like Cysteine Proteinases and Metastasis

  • Bonnie F. Sloane
  • Jurij Rozhin
  • Randall E. Ryan
  • Tamara T. Lah
  • Nancy A. Day
  • John D. Crissman
  • Kenneth V. Honn
Part of the Developments in Oncology book series (DION, volume 40)


During the process of metastasis tumor cells traverse several extracellular matrix barriers in order to gain entry to the vascular space at the site of the primary tumor and to the perivascular space at the sites of metastatic tumors. A number of in vitro model systems have been designed to study tumor cell invasion through extracellular matrices. Several of these model systems including systems to study the concomitant digestion of these matrices by tumor cells are discussed elsewhere in this volume (see Chapters 18–21). A focus of much recent research is the basement membrane which underlies endothelial cells. The physical location of the basement membrane suggests that it must be traversed for tumor cells to form hematogenous metastases. Since the basement membrane in contrast to other extracellular matrix barriers contains type IV collagen a number of investigators have hypothesized that tumor cells must be able to degrade type IV collagen in order to invade through the basement membrane (see also Chapter 19). Metastatic variants of the B16 melanoma have been shown to secrete a type IV collagenase (1). However, type IV collagenase is secreted by tumor cells in a latent form which requires activation (2) suggesting that type IV collagenase is not by itself sufficient for basement membrane invasion by tumor cells and that additional proteinases or a proteolytic cascade may participate in basement membrane invasion.


Cysteine Proteinase Cysteine Proteinase Inhibitor Plasma Membrane Fraction Lipoxygenase Product Centrifugal Elutriation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (London) 284: 61–62, 1980.CrossRefGoogle Scholar
  2. 2.
    Salo T, Liotta LA, Tryggvason K: Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. J. Biol. Chem. 257: 3058–3063, 1983.Google Scholar
  3. 3.
    Kuhn K: Collagen family-variations in the molecular and super-molecular structures. In: Tschesche H (ed.) Proteinases in Inflammation and Tumor Invasion. Walter de Gruyter & Co., Berlin, in press.Google Scholar
  4. 4.
    Crissman JD, Hatfield J, Schaldenbrand M, Sloane BF, Honn KV: Arrest and extravasation of B16 amelanotic melanoma in murine lungs. Lab. Invest., in press.Google Scholar
  5. 5.
    Jones PA, DeClerck YA: Extracellular matrix destruction by invasive tumor cells. Cancer Metastasis Rev. 1: 289–317, 1982.PubMedCrossRefGoogle Scholar
  6. 6.
    Barrett AJ: The many forms and functions of cellular proteinases. Fed. Proc. Fed. Am. Soc. Exp. Biol. 39: 9–14, 1980.Google Scholar
  7. 7.
    Barrett AJ, McDonald JK: Mammalian Proteases. Academic Press, New York, Vol. 1, 1980.Google Scholar
  8. 8.
    Neurath H: Evolution of proteolytic enzymes. Science 224: 350–357, 1984.PubMedCrossRefGoogle Scholar
  9. 9.
    Barrett AJ: Human cathepsin B1. Purification and some properties of the enzyme. Biochem. J. 131: 809–822, 1973.PubMedGoogle Scholar
  10. 10.
    Willenbrock F, Brocklehurst K: Preparation of cathepsins B and H by covalent chromatography and characterization of their catalytic sites by reaction with a thiol-specific two-protonic-state reactivity probe. Biochem. J. 227: 511–519, 1985.PubMedGoogle Scholar
  11. 11.
    Willenbrock F, Brocklehurst K: A general framework of cysteineproteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and -161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Biochem. J. 227: 521–528, 1985.PubMedGoogle Scholar
  12. 12.
    Mason RW, Green GDJ, Barrett AJ: Human liver cathepsin L. Biochem. J. 226: 233–241, 1985.PubMedGoogle Scholar
  13. 13.
    Schwartz WN, Bird JWC: Degradation of myofibrillar proteins by cathepsins B and D. Biochem. J. 167: 811–820, 1977.PubMedGoogle Scholar
  14. 14.
    Noda T, Isogai K, Hayashi H, Katunuma N: Susceptibilities of various myofibrillar proteins to cathepsin B and morphological alteration of isolated myofibrils by this enzyme. J. Biochem. (Tokyo) 90: 371–379, 1981.Google Scholar
  15. 15.
    McKay MJ, Offermann MK, Barrett AJ, Bond JS: Action of human liver cathepsin B on oxidized insulin B chain. Biochem. J. 213: 467–471, 1983.PubMedGoogle Scholar
  16. 16.
    Morrison RIG, Barrett AJ, Dingle JT: Cathepsins B1 and D action on human cartilage proteoglycans. Biochim. Biophys. Acta 302: 411–419, 1973.PubMedGoogle Scholar
  17. 17.
    Recklies AD, Poole AR: Proteolytic mechanisms of tissue destruction in tumor growth and metastasis. In: Weiss L, Gilbert HA (eds.) Liver Metastasis. GK Hall, Boston, pp. 77–95, 1982.Google Scholar
  18. 18.
    Burleigh MC, Barrett AJ, Lazarus GS: Cathepsin B1. A lysosomal enzyme that degrades native collagen. Biochem. J. 137: 387–398, 1974.PubMedGoogle Scholar
  19. 19.
    Etherington DJ: The dissolution of insoluble bovine collagens by cathepsin B1, collagenolytic cathepsin and pepsin. Conn. Tisa. Res. 5: 135–145, 1977.CrossRefGoogle Scholar
  20. 20.
    Aronson NN, Barrett AJ: The specificity of cathepsin B. Hydrolysis of glucagon at the C-terminus by a peptidyldipeptidase mechanism. Biochem. J. 171: 759–765, 1978.PubMedGoogle Scholar
  21. 21.
    Bond JS, Barrett AJ: Degradation of fructose-1–6-biphosphate aldolase by cathepsin B. A further example of peptidyldipeptidase activity of this proteinase. Biochem. J. 189: 17–25, 1980.PubMedGoogle Scholar
  22. 22.
    Eeckhout Y, Vaes G: Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem. J. 166: 21–31, 1977.PubMedGoogle Scholar
  23. 23.
    Rosenfeld MG, Kreibich G, Popov D, Kato K, Sabatini DD: Biosynthesis of lysosomal hydrolases: Their synthesis in bound polysomes and the role of co-and post-translational processing in determining their subcellular distribution. J. Cell Biol. 93: 135–143, 1982.PubMedCrossRefGoogle Scholar
  24. 24.
    Sly WS, Fischer HD: The phosphomannosyl recognition system for intracellular and intercellular transport of lysosomal enzymes. J. Cell. Biochem. 18: 67–85, 1982.PubMedCrossRefGoogle Scholar
  25. 25.
    Neufeld EF, Lim TW, Shapiro LJ: Inherited disorders of lysosomal metabolism. Annu. Rev. Biochem. 44: 357–376, 1975.PubMedCrossRefGoogle Scholar
  26. 26.
    Skudlarek MD, Swank RT: Turnover of two lysosomal enzymes in macrophages. J. Biol. Chem. 256: 10137–10144, 1981.PubMedGoogle Scholar
  27. 27.
    Sloane BF, Honn KV, Sadler JG, Turner WA, Kimpson JJ, Taylor JD: Cathepsin B activity in B16 melanoma cells: A possible marker for metastatic potential. Cancer Res. 42: 980–986, 1982.PubMedGoogle Scholar
  28. 28.
    Pietras RJ, Szego CM, Roberts JA, Seeler BJ: Lysosomal cathepsin B-like activity: Mobilization in prereplicative and neoplastic epithelial cells. J. Histochem. Cytochem. 29: 440–450, 1981.PubMedCrossRefGoogle Scholar
  29. 29.
    Honn KV, Cavanaugh P, Evens C, Taylor JD, Sloane BF: Tumor cell-platelet aggregation: Induced by cathepsin B-like proteinase and inhibited by prostacyclin. Science 217: 540–542, 1982.PubMedCrossRefGoogle Scholar
  30. 30.
    Cavanaugh PG, Sloane BF, Bajkowski A, Gasic GJ, Gasic TB, Honn KV: Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clin. Exp. Metastasis 1: 297–308, 1983.PubMedCrossRefGoogle Scholar
  31. 31.
    Sloane BF, Sadler JG, Evens C, Ryan R, Bajkowski AS, Crissman JD, Honn KV: Cathepsin B-like cysteine proteinasea and tumor metastasis. Cancer Bull. 36: 196–200, 1984.Google Scholar
  32. 32.
    Sloane BF, Makim S, Dunn JR, Lacoste R, Theodorou M, Battista J, Alex R, Honn KV: In: Bockman RS, Powles T, Honn KV, Ramwell P (eds.) Prostaglandins and Cancer. Alan Liss, New York, pp. 789–792, 1982.Google Scholar
  33. 33.
    Mort JS, Leduc M, Recklies AD: A latent thiol proteinase from ascitic fluid of patients with neoplasia. Biochim. Biophys. Acta 662: 173–180, 1981.PubMedGoogle Scholar
  34. 34.
    Mort JS, Leduc M, Recklies AD: Characterization of a latent cysteine proteinase from ascitic fluid as a high molecular weight form of cathepsin B. Biochim. Biophys. Acta 755: 369–375, 1983.PubMedGoogle Scholar
  35. 35.
    Pietras RJ, Szego CM, Mangan CE, Seeler BJ, Burtnett MM, Orevi M: Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure. Obstet. Gynecol. 52: 321–327, 1978.PubMedGoogle Scholar
  36. 36.
    Pietras RJ, Szego CM, Mangan CE, Seeler BJ, Burtnett MM: Elevated serum cathepsin B1-like activity in women with neoplastic disease. Gynecol. Oncol. 7: 1–17, 1979.PubMedCrossRefGoogle Scholar
  37. 37.
    Perras RJ, Cramer J, Bishop R, Averette H, Sevin BU: Detection of increased levels of cysteinyl proteinase activity in urine of gynecological cancer patients. Proc. Am. Assoc. Cancer Res. 24: 130, 1983.Google Scholar
  38. 38.
    Perras JP, Sevin BU: Production of monoclonal antibodies against cathepsin B-like enzyme derived from urine of gynecologic cancer patients. Proc. Am. Assoc. Cancer Rea. 25: 250, 1984.Google Scholar
  39. 39.
    Dufek V, Matous B, Kral V: Serum alkaline-stable acid thiol proteinase–a possible marker for primary liver carcinoma. Neoplasms 31: 99–107, 1984.Google Scholar
  40. 40.
    Vasishta A, Baker PR, Preece PE, Wood RAB, Cuschieri A: Serum and tissue proteinase-like peptidase activities in women undergoing total mastectomy for breast cancer. Eur. J. Clin. Oncol. 20: 203–208, 1984.CrossRefGoogle Scholar
  41. 41.
    Poole AR, Tiltman KJ, Recklies AD, Stoker TAM: Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature (London) 273: 545–547, 1980.CrossRefGoogle Scholar
  42. 42.
    Recklies AD, Tiltman KJ, Stoker TAM, Poole AR: Secretion of proteinasea from malignant and nonmalignant human breast tissue. Cancer Res. 40: 550–556, 1980.PubMedGoogle Scholar
  43. 43.
    Recklies AD, Mort JS, Poole AR: Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization. Cancer Res. 42: 1026–1032, 1982.PubMedGoogle Scholar
  44. 44.
    Baici A, Gyger-Marazzi M, Strauli P: Extracellular cysteine proteinase and collagenase activities as a consequence of tumor-host interaction in the rabbit V2 carcinoma. Invasion Metastasis 4: 13–27, 1984.PubMedGoogle Scholar
  45. 45.
    Bokoch GM, Reed PW: Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes. J. Biol. Chem. 256: 5317–5320, 1981.PubMedGoogle Scholar
  46. 46.
    Hafstrom I, Pamblad J, Malaten CL, Radmark 0, Samuelason B: Leukotriene B4–a stereospecific stimulator for release of lysosomal enzymes from neutrophils. FEBS Lett. 130: 146–148, 1981.PubMedCrossRefGoogle Scholar
  47. 47.
    Walenga RW, Showell HJ, Feinstein MB, Becker EL: Parallel inhibition of neutrophil arachidonic acid metabolism and lysosomal enzyme secretion by nordihydroguaiaretic acid. Life Sci. 27: 1047–1053, 1980.PubMedCrossRefGoogle Scholar
  48. 48.
    Smith RJ, Sun FF, Bowman BJ, Iden SS, Smith HW, McGuire JC: Effect of 6,9-diepoxy-6,9-(phenylimino)-∆6,8-prostaglandin I1 (U-60–257) an inhibitor of leukotriene synthesis on human neutrophil function. Biochem. Biophys. Res. Commun. 109: 943–949, 1982.PubMedCrossRefGoogle Scholar
  49. 49.
    Sloane BF, Honn KV: Proteolytic enzymes and arachidonic acid metabolites. In: Lands WEM (ed.) Biochemistry of Arachidonic Acid Metabolism. Martinus Nihhoff, Boston, pp. 311–321, 1985.CrossRefGoogle Scholar
  50. 50.
    Sloane BF, Honn KV: Cysteine proteinases and metastasis. Cancer Metastasis Rev. 3: 249–263, 1984.PubMedCrossRefGoogle Scholar
  51. 51.
    Pietras RJ, Roberts JA: Cathepsin B-like enzymes. Subcellular distribution and properties in neoplastic and control cells from human ectocervix. J. Biol. Chem. 256: 8536–8544, 1981.PubMedGoogle Scholar
  52. 52.
    Zucker S, Lysik RM, Wieman J, Wilkie D, Lane B: Tumor cell membrane metalloproteinases are responsible for collagenolysis and cell destruction during cancer invasion. Proc. Am. Assoc. Cancer Res. 26: 56, 1985.Google Scholar
  53. 53.
    Koppel P, Baici A, Keist R, Matzku S, Keller R: Cathepsin B-like proteinase as a marker for metastatic tumor cell variants. Exp. Cell Biol. 52: 293–299, 1984.PubMedGoogle Scholar
  54. 54.
    Bohmer FD, Schmidt HE, Schon R: Proteolytic activities associated with plasma membrane preparations from tumour cells in enzootic bovine leukosis and from normal bovine lymphoid cells. Acta Biol. Med. Germ. 41: 883–890, 1982.Google Scholar
  55. 55.
    Kozlowski KA, Wezeman FH, Schultz RM: Tumor cell proteinase visualization and quantification using a fluorescent transition-state analog probe. Proc. Natl. Acad. Sci. USA 81: 1135–1139, 1984.PubMedCrossRefGoogle Scholar
  56. 56.
    Gasic GJ, Catalfamo JL, Gasic TB, Avdalovic N. In vitro mechanisms of platelet aggregation by purified plasma membrane vesicles shed by mouse 15091A tumor cells. In: Donati MB, Davidson JF, Garattini S (eds.) Malignancy and the Hemostatic System. Raven Press, New York, pp. 27–35, 1981.Google Scholar
  57. 57.
    Gasic GJ, Boettiger D, Catalfamo JL, Gasic TB, Stewart GJ: Aggregation of platelets and cell membrane vesiculation by rat cells transformed in vitro by Rous sarcoma virus. Cancer Res. 38: 2950–2955, 1978.PubMedGoogle Scholar
  58. 58.
    Poste G, Nicolson GL: Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc. Natl. Acad. Sci USA 77: 399–403, 1980.PubMedCrossRefGoogle Scholar
  59. 59.
    Sloane BF, Dunn JR, Honn KV: Lysosomal cathepsin B: Correlation with metastatic potential. Science 212: 1151–1153, 1981.PubMedCrossRefGoogle Scholar
  60. 60.
    Sloane BF, Rozhin J, Crissman JD, Bajkowski AS, Honn KV: Association of a cathepsin B-like cysteine proteinase with tumor cell plasma membranes. In: Hellmann K and Eccles SA (eds.) Treatment of Metastasis: Problems and Prospects. Taylor and Francis, London, pp. 377–380, 1985.Google Scholar
  61. 61.
    Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV: Cathepsin B: A plasma membrane enzyme in metastatic tumors. Submitted.Google Scholar
  62. 62.
    Steven FS, Griffin MM, Itzhaki S, Al-Habib A: A trypsin-like neutral protease on Ehrlich ascites cell surfaces: Its role in the activation of tumour-cell zymogen of collagenase. Br. J. Cancer 42: 712–721, 1980.PubMedCrossRefGoogle Scholar
  63. 63.
    Steven FS, Griffin MM, Itzhaki S: Inhibition of free and bound trypsin-like enzymes. Eur. J. Biochem. 126: 311–318, 1982.PubMedCrossRefGoogle Scholar
  64. 64.
    Campbell EJ, Senior RM, McDonald JA, Cox DL: Proteolysis by neutrophils. Relative importance of cell-substrate contacts and oxidative inactivation of proteinase inhibitors in vitro. J. Clin. Invest. 70: 845–852, 1982.PubMedCrossRefGoogle Scholar
  65. 64a.
    Johnson KJ, Varani J: Substrate hydrolysis by immune complex-activated neutrophils: Effect of physical presentation of complexes and protease inhibitors. J. Immunol. 127: 1875–1879, 1981PubMedGoogle Scholar
  66. 65.
    Sloane BF, Bajkowski AS, Day NA, Honn KV, Crissman JD: Purification and properties of a cathepsin B-like enzyme from human tumors: Comparison with cathepsin B isolated from human liver and spleen. Proc. Am. Assoc. Cancer Res. 25: 4, 1984.Google Scholar
  67. 66.
    Olstein AD, Liener IE: Comparative studies of mouse liver cathepsin B and an analogous tumor thiol proteinase. J. Biol. Chem. 258: 11049–11056, 1983.PubMedGoogle Scholar
  68. 67.
    Ryan RE, Crissman JD, Honn KV, Sloane BF: Cathepsin B-like activity in viable tumor cells isolated from rodent tumors. Cancer Res., in press.Google Scholar
  69. 68.
    McLaughlin MEH, Liener IE, Wang N: Proteolytic and metastatic activities of clones derived from a methylcholanthrene-induced murine fibrosarcoma. Clin. Exp. Metastasis 1: 359–372, 1983.PubMedCrossRefGoogle Scholar
  70. 69.
    Takenaga K: Enhanced metastatic potential of cloned low-metastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide. Cancer Res. 44: 1122–1127, 1984.PubMedGoogle Scholar
  71. 70.
    Lowe FC, Isaacs JT: Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the Dunning R-3327 rat prostatic adenocarcinoma system as a model. Cancer Res. 44: 744–752, 1984.PubMedGoogle Scholar
  72. 71.
    Meistrich ML, Grdina DJ, Meyn RE, Barlogie B: Separation of cells from mouse solid tumors by centrifugal elutriation. Cancer Res. 37: 4291–4296, 1977.PubMedGoogle Scholar
  73. 72.
    Meistrich ML, Meyn RE, Barlogie B: Synchronization of mouse L-P59 cells by centrifugal elutriation separation. Exp. Cell Res. 105: 169–177, 1977.PubMedCrossRefGoogle Scholar
  74. 73.
    Bauer KD, Keng PC, Sutherland RM: Isolation of quiescent cells from multicellular tumor spheroids using centrifugal elutriation. Cancer Res. 42: 72–78, 1982.PubMedGoogle Scholar
  75. 74.
    Bosmann HB, Bieber GF, Brown AE, Case KR, Gersten DM, Kimmerer TW, Lione A: Biochemical parameters correlated with tumor cell implantation. Nature (London) 246: 487–489, 1973.CrossRefGoogle Scholar
  76. 75.
    Nicolson GL, Brunson KL, Fidler IJ: Tumor cell surfaces: Some characteristics of neoplastic cells that determine states of transformation and malignancy. Acta Histochem. Cytochem. 10: 114–133, 1977.CrossRefGoogle Scholar
  77. 76.
    Dolbeare F, Vanderlaan M, Phares W: Alkaline phosphatase and acid arylamidase as marker enzymes for normal and transformed WI-38 cells. J. Histochem. Cytochem. 28: 419–426, 1980.PubMedCrossRefGoogle Scholar
  78. 77.
    Morgan RA, Inge KL, Christopher CW: Localization and characterization of N-ethylmaleimide sensitive inhibitor(s) of thiol cathepsin activity from cultured Nil and polyoma virus-transformed Nil hamster cells. J. Cell. Physiol. 108: 55–66, 1981.PubMedCrossRefGoogle Scholar
  79. 78.
    Burnett D, Crocker J, Vaughn ATM: Synthesis of cathepsin B by cells derived from the HL60 promyelocytic leukemia cell line. J. Cell. Physiol. 115: 249–254, 1983.PubMedCrossRefGoogle Scholar
  80. 79.
    Miner KM, Kawaguchi T, Uba GW, Nicolson GL: Clonai drift of cell surface, melanogenic, and experimental metastatic properties of in vivo selected, brain meninges-colonizing muring B16 melanoma. Cancer Res. 42: 4631–4638, 1982.PubMedGoogle Scholar
  81. 80.
    Welch DR, Nicolson GL: Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to Adriamycin, 5-fluoro-2’-deoxyuridine and methotrexate treatment in vitro. Clin. Exp. Metastasis 1: 317–325, 1983.PubMedCrossRefGoogle Scholar
  82. 81.
    Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C: Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 33: 3239–3249, 1973.PubMedGoogle Scholar
  83. 82.
    Poste G: Methods and models for studying tumor invasion. In: Liotta LA and Hart IR (eds.) Tumor Invasion and Metastasis. Martinus Nijhoff, The Hague, pp. 147–171, 1982.Google Scholar
  84. 83.
    Chu FF, Olden K: Distribution of acid hydrolases in subcellular fractions of proliferating versus non-proliferating fibroblasts. Exp. Cell Res. 154: 606–612, 1984.PubMedCrossRefGoogle Scholar
  85. 84.
    Lah TT, Rozhin J, Honn KV, Crissman JD, Sloane BF: Human tumor cysteine proteinase inhibitors: Reduced affinity against cathepsin B. J. Cell Biol., in press.Google Scholar
  86. 85.
    Jarvinen M, Rinne A: Human spleen cysteineproteinase inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants. Biochim. Biophys. Acta 708: 210–217, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1986

Authors and Affiliations

  • Bonnie F. Sloane
  • Jurij Rozhin
  • Randall E. Ryan
  • Tamara T. Lah
  • Nancy A. Day
  • John D. Crissman
  • Kenneth V. Honn

There are no affiliations available

Personalised recommendations